ZAFBENA Trademark

Trademark Overview

On Monday, December 20, 2021, a trademark application was filed for ZAFBENA with the United States Patent and Trademark Office. The USPTO has given the ZAFBENA trademark a serial number of 97180767. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, December 9, 2024. This trademark is owned by BendaRx Corp.. The ZAFBENA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in oncology and pharmaceutical preparations to treat cancer
zafbena

General Information

Serial Number97180767
Word MarkZAFBENA
Filing DateMonday, December 20, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, December 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations for use in oncology and pharmaceutical preparations to treat cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBendaRx Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAlexandria, VA 22314
Party NameBendaRx Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlexandria, VA 22314

Trademark Events

Event DateEvent Description
Saturday, September 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 23, 2021NEW APPLICATION ENTERED
Monday, December 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 24, 2022ASSIGNED TO EXAMINER
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 16, 2023ASSIGNED TO EXAMINER
Monday, June 26, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 26, 2023SOU EXTENSION 1 FILED
Monday, June 26, 2023SOU EXTENSION 1 GRANTED
Monday, June 26, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, June 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 26, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 26, 2023SOU EXTENSION 2 FILED
Tuesday, December 26, 2023SOU EXTENSION 2 GRANTED
Thursday, December 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2024SOU EXTENSION 3 GRANTED
Monday, June 24, 2024SOU EXTENSION 3 FILED
Monday, December 9, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 9, 2024SOU EXTENSION 4 FILED
Tuesday, December 10, 2024SOU EXTENSION 4 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

zafbena pharmaceutical preparations cancer oncology treat